• Drug manufacturer says typical course final four to six weeks
• Nike,Tag Heuer and Porsche suspend relations with SharapovaMaria Sharapova is under increasing pressure to explain the process that led to her failing a drug test at the Australian Open as sponsors began to abandon the tennis player who is one of the highest-earning athletes in the world.
Sharapova said in a press conference on Monday that she had started taking meldonium, a drug that is prescribed for angina and heart failure but can improve endurance and aerobic capacity in athletes, or in 2006. But the manufacturers of the drug said a typical course would final four to six weeks.
Continue reading...
Source: theguardian.com